Nuclear factor (NF) 90 and NF45 are each zinc-fi nger DNA-and RNA-binding proteins purifi ed and cloned from activated T cells based on their specifi c binding to the A-T-rich purine-box/antigen receptor response element (ARRE)/NFAT site in the IL-2 promoter (1, 2). NF90 also contains two double-stranded RNA-binding motifs that bind IL-2 and other RNAs (3) (4) (5) . Antisera to NF90 and NF45 specifi cally inhibited ARRE/NFAT DNA binding and in vitro transcription (2) . NF90 and NF45 copurify with two systemic lupus erythematosis autoantigens, Ku80 and Ku70, and the catalytic subunit of DNA-dependent protein kinase (6) . Monoclonal antibodies against Ku80 and Ku70 specifi cally inhibited ARRE DNA binding (7, 8) .
Proteins with double-stranded RNA-binding motifs-such as NF90 (also referred to as IL enhancer binding factor 3), RNA helicase A, adenosine-to-inosine editase (RNA-specifi c adenosine deaminase [ADA] ), staufen, protein kinase R, and Dicer-can bind structured nucleic acids and regulate gene expression at the levels of transcription, RNA processing and transport, translation, and RNA interference (9) . NF90 regulates transcription (10) (11) (12) , posttranscriptional RNA stabilization (3, 5) , nuclear export (3), and translation (4, 13) . NF90 has been implicated in host antiviral responses and as a cellular cofactor involved in viral replication and translation (9, 13, 14) .
The ARRE site serves a unique role in regulating IL-2 transcription: a specifi c transcriptional repressor preexisting in the nucleus of resting T cells is converted during T cell activation into a potent transcriptional activator (15) . DNA-footprinting experiments demonstrated that proteins bound to the distal ARRE-2 site in the IL-2 proximal promoter in resting Jurkat and EL-4 T cells and T cell activation expanded the footprint of this purine-box
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Lingfang Shi, 1 Wayne R. Godfrey, 2 Joseph Lin, 1 Guohua Zhao, 1 and Peter N. Kao 1 regulator complex (16, 17) . The ARRE site was proposed as key for regulating chromatin melting and providing concerted access of all other transcription factors to the IL-2 promoter (18) . This model predicts that targeted disruption of the genes that encode critical regulators operating at the purine-box/NFAT site in the IL-2 promoter may confer phenotypes of defective IL-2 transcription and T cell activation and may exhibit T cell immunodefi ciency in vivo.
To elucidate the roles of NF90 in development and immune regulation, we generated mice with a targeted disruption of NF90. NF90 −/− mice die within 6 h of birth because of diaphragmatic respiratory failure related to insuffi cient expression of the myogenic regulators MyoD, myogenin, and p21Cip1/Waf1 (5). To circumvent the perinatal lethality of the NF90-defi cient mice, we transplanted NF90 fetal liver cells into irradiated recombination activating gene (RAG)-2 −/− /IL-2Rγ −/− mice that lack T cells, B cells, and NK cells and characterized immune reconstitution and function in the NF90-RAGγ chimeric mice. In this report, we demonstrate that NF90 inducibly binds to the IL-2 promoter and regulates ARRE/NFAT and IL-2 transcriptional activation, IL-2 mRNA stability, IL-2 gene expression, and peripheral T lymphocyte survival in vivo.
RESULTS AND D I S C U S S I O N NF90 binds specifi cally to the IL-2 promoter in vivo in activated T cells
We used chromatin immunoprecipitation (ChIP) to characterize in vivo binding of NF90 to the IL-2 proximal promoter, to IL-2 intron 3 (2.5 kB removed), and to the ADA origin of DNA replication to which Ku80 and Ku70 specifically bind in vivo ( Fig. 1) (19) . Primary mouse spleen cells were nonstimulated or stimulated for 4 h with PMA + ionomycin (PMA/Iono) and treated with 1% formaldehyde to cross-link transcription factors to their chromatin targets in vivo. Genomic PCR of sheared and restricted input chromatin demonstrated equal amplifi cation of all targets from nonstimulated and stimulated cells (Fig. 1 A) . We performed NF90 ChIP using a monoclonal antibody and showed specifi c binding to the IL-2 proximal promoter in vivo that increased upon stimulation (Fig. 1, B , lane 2 vs. lane 1), and no binding to IL-2 intron 3 ( Fig. 1 B, lanes 3 and 4) . NF90 bound equally to the ADA origin of DNA replication in nonstimulated and stimulated spleen cells (Fig. 1 B , lanes 5 and 6). Control antibody against hemagglutinin (HA) epitope did not precipitate the IL-2 promoter, intron 3, or ADA chromatin targets in our experimental conditions (Fig. 1 C) . This ChIP result validates our original purifi cation using EMSA that identifi ed NF90 and NF45 as subunits of an inducible ARRE/NFAT DNA-binding complex in the nucleus of Jurkat T cells (1) .
NF90 genotype determines phenotype of maximal IL-2 gene expression Adult NF90 heterozygous mice are indistinguishable from wildtype NF90 littermates in terms of size, activity, and longevity.
We examined whether adult NF90 heterozygous mice might express less IL-2 than wild-type littermates. Compared with NF90 +/+ mice, thymocytes and splenocytes from NF90 +/− mice stimulated with PMA/Iono for 6, 12, and 18 h produced ‫%05ف‬ less IL-2 ( Fig. 2 A) . We also characterized maximal IL-2 gene expression by newborn NF90 +/+ , NF90 +/− , and NF90 −/− littermates (Fig. 2 B) . Compared with NF90 +/+ mice, lymphocytes from NF90 +/− and NF90 −/− mice stimulated with PMA/Iono for 6 h mice demonstrat ed moderate and severe impairment of IL-2 expression. The substantial reduction in IL-2 expression in NF90 gene-targeted mice as early as 6 h suggests that expression levels of NF90 regulate transcriptional activation of the IL-2 gene. We performed four independent NF90 fetal liver transplantation experiments that generated 21 NF90-RAGγ chimeric mice. A total of 10 NF90 −/− -RAGγ animals were compared with 10 NF90 +/+ -or NF90 +/− -RAGγ chimeric littermates. Complete blood counts demonstrated no substantial defects in the reconstitution of erythroid, myeloid, or megakaryocytic lineages. The most consistent defect we observed in NF90 −/− -RAGγ chimeras was lymphocytopenia (Table I) . mice were substantially larger than in adult RAGγ-null mice and were approximately two thirds the size of wild-type donor mice. We analyzed surface expression of CD4, CD8, CD3, and CD45R-B220 on thymocytes and splenocytes (Fig. 2 C) . The thymi of all NF90-RAGγ chimeric mice contained a major population of CD4 + and CD8 + (double-positive) thymocytes (Fig. 2 C, row 1) . The spleens of all NF90-RAGγ chimeric mice showed maturation of T cells to CD4 + or CD8 + (single-positive) T cells. B cells represented 70-80% of splenic lymphocytes (Fig. 2 C, row 2) . We consistently observed a modest decrease in splenic CD4 + T cells and a moderate decrease in CD8 + T cells between the NF90 −/− -RAGγ and NF90 +/− -or NF90 +/+ -RAGγ chimeras (Fig.  2 C, row 2) . The reconstitution of T cells and B cells in the NF90 −/− -RAGγ chimeras demonstrated that NF90 is not absolutely required for T or B cell development.
BRIEF DEFINITIVE REPORT
Analyses of lymphocyte subsets in peripheral blood at 4 and 9 wk after transplantation revealed no reconstitution of T cells in NF90 −/− -RAGγ chimeras compared with NF90 +/+ -and NF90 +/− -RAGγ chimeras. We observed severe deficiencies of CD4 + and CD8 + T cells only in NF90 −/− -RAGγ chimeric animals (Fig. 2 C, row 3 ). This T cell lymphocytopenia was present in fi ve out of six NF90 −/− -RAGγ chimeras compared with zero out of seven NF90 +/− -or NF90 +/+ -RAGγ chimeras. The residual lymphocytes in the peripheral circulation of NF90 −/− -RAGγ chimeras were predominantly B cells. From this result, we infer that NF90 is necessary for T cell survival in the blood but not in the spleen.
Spleen cells were analyzed for the proportion of CD4 + CD25 + regulatory T cells (Fig. 2 C, rows 4 We characterized IL-2 production by NF90-RAGγ chimeric thymocytes, splenocytes, and purifi ed splenic CD4 + T cells in response to primary stimulations for 16 h with PMA/Iono and anti-CD3 + CD28 (Fig. 2 D) . Stimulated NF90 −/− -RAGγ chimeric T cells (eight mice) consistently demonstrated severely reduced IL-2 expression compared with NF90 +/+ or NF90 +/− -RAGγ T cells (seven littermate mice).
NF90 −/− thymocytes are impaired in ARRE/NFAT transcriptional activation
To address the mechanisms of impaired IL-2 expression in T cells lacking NF90, we characterized transcriptional activation of an ARRE/NFAT luciferase reporter gene transfected into NF90 +/+ , NF90 +/− , and NF90 −/− thymocytes (Fig. 3 A) . Compared with NF90 +/+ and NF90 +/− cells, NF90 −/− thymocytes demonstrated severe impairment of ARRE/NFAT transcriptional activation upon stimulation (Fig. 3 A) .
NF90 transcriptionally activates an ARRE/NFAT luciferase reporter gene in Jurkat T cells
We recently reported that transgenic overexpression of NF45 in Jurkat T cells conferred 120-fold enhancement of IL-2 promoter-and NFAT-luciferase reporter gene activation (20) . In this paper we demonstrate that stable transgenic expression of NF90 in Jurkat T cells is associated with 70-80-fold specifi c enhancement of ARRE/NFAT luciferase reporter gene activation in nonstimulated and PMA/Iono-stimulated T cells (Fig. 3 B) . These results indicate that NF90 and NF45 specifi cally transactivate the ARRE sequence in activated T cells.
NF90 −/− thymocytes are impaired in IL-2 gene transcription
We performed ChIP to examine recruitment and binding of the large subunit of RNA polymerase II to the IL-2 proximal promoter in nonstimulated and stimulated NF90 +/+ and Conditioning radiation for BMT was 450 cGy and for BMT2 was 900 cGy. Abnormal values are identifi ed by L (low) and shown in bold.
BRIEF DEFINITIVE REPORT
NF90 −/− thymocytes. In nonstimulated T cells, we observed no binding of RNA pol II to the chromatin at the IL-2 proximal promoter, consistent with a closed chromatin conformation and no transcription. Wild-type thymocytes stimulated with anti-CD3/CD28 showed prominent induction of RNA pol II binding to the IL-2 promoter, consistent with transcriptional activation (Fig. 3 C, lanes 2 and 4 vs. lanes 1 and 3) . In contrast, NF90-defi cient thymocytes showed substantially reduced binding of RNA pol II to the IL-2 promoter upon stimulation (Fig. 3 C, lanes 6 and 8 vs. lanes 2 and 4) . This result supports our conclusion that NF90 regulates inducible IL-2 transcription.
NF90 binds to and stabilizes IL-2 RNA
We used Northwestern blotting to demonstrate that NF90 is a principal IL-2 3′ untranslated region (UTR) RNAbinding protein (Fig. 3 D) (3) . Brain extracts are suitable for these studies because NF90 is highly expressed in the brain (5), and IL-2 is expressed in rodent brains (21) . A 90-kD protein with the same electrophoretic mobility and IL-2 RNA-binding properties as recombinant NF90 is present in NF90 +/+ extracts and is absent in extracts prepared from NF90 −/− mice. We observed similar results with NF90 −/− neonatal thymocytes and a shorter IL-2 RNA probe that contains the four proximal ARREs (unpublished data). We examined IL-2 mRNA stability in splenocytes from newborn NF90 +/+ and NF90 −/− mice. Upon stimulation with anti-CD3/CD28, NF90 +/+ splenocytes prominently induced IL-2 mRNA ( (Fig. 3 F) . Assuming fi rst order exponential decay kinetics, the IL-2 mRNA half-life in NF90 +/+ mice is 37 min, whereas the IL-2 mRNA half-life in NF90 −/− mice is 12 min. Thus, NF90 binds to and stabilizes newly transcribed IL-2 RNA, thereby posttranscriptionally enhancing IL-2 gene expression. We propose that NF90 regulates and facilitates rapid expression of IL-2 and other important, tightly controlled genes (including MyoD and p21Cip1) (5) . T cell activation triggers IL-2 chromatin remodeling that increases the binding of NF90 and RNA polymerase II to the IL-2 proximal promoter in vivo, as revealed by ChIP. NF90 regulates transcriptional activation through the ARRE sequence in the IL-2 proximal promoter in activated T cells. NF90-defi cient thymocytes exhibit specifi c impairment of ARRE/ NFAT-regulated transcriptional activation and binding of RNA pol II to the IL-2 promoter upon stimulation. Binding of newly transcribed IL-2 RNA to NF90 stabilizes the transcript against degradation (3). Operating as an RNA chaperone, NF90 regulates nuclear export of IL-2 RNA and can associate with ribosomes and regulate protein translation (4, 13) .
Purine-box regulator ARRE DNA-binding subunits NF90, NF45, Ku80, and Ku70 (1, 2, 7, 8) are distinct from the ‫-021ف‬kD NFAT proteins isolated from T cell cytoplasm (23) . Both NF90 and NFAT proteins can specifi cally bind to the same ARRE sequence in vitro. Our ChIP results demonstrate inducible binding of NF90 to the IL-2 proximal promoter in vivo. Targeted disruptions of individual NFAT proteins failed to impair IL-2 gene expression, which prompted the characterization of NFATc1 and NFATc2 double-knockout (DKO) fetal liver-RAG chimeric mice (24) . These DKO mice showed normal reconstitution of T cells and B cells, but in vitro cultured DKO T cells showed defi cient IL-2 production when restimulated with anti-CD3. It will be important to elucidate the relative contributions of NF90 and NFATs to regulating the individual steps of IL-2 gene expression.
Our study identifi es NF90 as an important regulator of T cell IL-2 transcription, mRNA stability, and gene expression and, therefore, a novel target for therapeutic modulation of T cell immune responses. The T cell lymphocytopenia associated with homozygous defi ciency of NF90 may be a consequence of attenuated proliferation or survival of circulating T cells caused by impaired expression of IL-2 or other genes. Future studies should also address the roles of NF90 as a host cellular factor that may be subverted during viral pathogenesis (9, 14, 25) .
MATERIALS AND METHODS
Animal studies. Animal studies were approved by the Stanford University Administrative Panel on Laboratory Animal Care.
ChIP. Mouse spleen cells (C57BL/6) were nonstimulated or stimulated for 4 h with 20 ng/ml PMA (Sigma-Aldrich) + 2 μM Iono (Calbiochem). 10 6 thymocytes per condition from newborn NF90 +/+ or NF90 −/− mice were nonstimulated or stimulated for 6 h with anti-CD3 + anti-CD28 (1 μg/ml each). Formaldehyde cross-linking and ChIP were performed as previously described (19) . Antibodies were against NF90 (mAb DRBP76; Becton Dickinson), HA (sc-805; Santa Cruz Biotechnology, Inc.), and the large subunit of RNA polymerease II (8WG16; Covance). PCR primers were as follows: IL-2 proximal promoter (299 bp), NF90 fetal liver-RAG transplantations. NF90 gene-targeted donor mice and RAG-2 −/− /IL-2Rγ −/− recipient mice were maintained on a C57BL/6 background. NF90 +/− mice were intercrossed and killed at E14-15, and fetal livers were dissociated into single-cell suspensions. Genomic DNA from embryonic skin was used for genotyping by PCR (5). Adult recipient RAG-2 −/− /IL-2Rγ −/− mice received conditioning radiation from a cesium source (450 or 900 cGy), followed within 24 h by tail vein injection of 4 × 10 6 NF90 +/+ , NF90 +/− , or NF90 −/− fetal liver cells.
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Flow cytometry. Engraftment and lymphocyte subsets in peripheral blood were monitored in NF90-RAG chimeric mice at 4 and 9 wk after transplantation. Peripheral blood mononuclear cells were labeled with anti-CD4, -CD8, -CD19, and -DX5 antibodies (Becton Dickinson) and analyzed by fl ow cytometry (LSR; Becton Dickinson) using FloJo software (TreeStar Inc.). NF90-RAGγ chimeras were killed at 15 wk after transplantation. Dissociated thymic and spleen cells were labeled with anti-CD4, -CD8, -CD25, -CD11b, -CD11c, and -B220 antibodies (Becton Dickinson) and analyzed by fl ow cytometry.
IL-2 analysis. Thymocytes, splenocytes, and CD4 + T cells (enriched by magnetic bead negative selection; Miltenyi Biotec) were stimulated (10 6 cells/ml) for 6-18 h with 20 ng/ml anti-CD3 (Becton Dickinson) + 20 ng/ml anti-CD28 (Becton Dickinson) or 20 ng/ml PMA + 2 μM Iono, and supernatants were analyzed by IL-2 ELISA (Becton Dickinson) in triplicate.
